About Lipomics
Lipomics is a company based in Sacramento (United States) founded in 2000 was acquired by Metabolon in August 2012. Lipomics operates in a competitive market with competitors including SD Biosensor, GEN inCode, SpectraWAVE, Lepu Medical Technology and Diadexus, among others.
- Headquarter Sacramento, United States
- SectorsHealthcare
- Website lipomics.com
- Social LinkedIn X
- Acquired by Metabolon (Aug 2012)
- Legal Name Lipomics Technologies, Inc
Investors in Lipomics
Lipomics has secured backing from 2 investors. Prominent investors backing the company include Metabolon and Tethys BioScience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Develops biological markers for medical diagnostic applications. | 2002 | tethysbio.com | Emeryville, United States | |
Solutions for biomarker discovery and diagnostic testing are provided. | 2000 | metabolon.com | Morrisville, United States |
Investor details for Lipomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Lipomics
3 dated milestones of Lipomics across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Lipomics is founded.
- Exit Acquired by Tethys BioScience.
- Exit Acquired by Metabolon.
Competitors of Lipomics
Lipomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, GEN inCode, SpectraWAVE, Lepu Medical Technology and Diadexus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| genincode.com | 2018 | Manchester, United Kingdom | $4.48M | 26 | Genetic and clinical data are integrated for precision cardiac medicines. | |
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| lepumedical.com | 1999 | Beijing, China | – | – | Interventional cardiology devices are developed and marketed globally. | |
| diadexus.com | 1997 | San Francisco, United States | $49.2M | – | Molecular diagnostic tests for cardiovascular disorders are developed and marketed. | |
| realviewimaging.com | 2008 | Yokneam Illit, Israel | $25M | – | 3D holographic display solutions for medical imaging are provided. | |
| bostonheartdiagnostics.com | 2007 | Framingham, United States | $10.34M | – | Diagnostics for personalized cardiovascular disease management are developed. | |
| prevenciomed.com | 2006 | Kirkland, United States | $5.68M | – | Protein-based diagnostics and prognostics for cardiovascular diseases are developed. | |
| proximdx.com | 2010 | Sunnyvale, United States | $22.9M | – | Handheld immunodiagnostic devices for cardiac vascular diseases are developed. | |
| spectrum-dynamics.com | 2000 | Morges, Switzerland | – | – | Cardiac imaging systems are manufactured using advanced molecular technologies. |
Detailed competitors of Lipomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lipomics
Websites that share an audience with Lipomics (lipomics.com).
Websites whose visitors overlap most with Lipomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| crownbio.com | 90% | 77K | #441,040 | View details | |
| innovativebiosensors.com | 65% | – | – | View details | |
| pegamedical.com | 65% | – | – | View details |
Similar companies to Lipomics
10 companies that operate in the same segment as Lipomics (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lipomics
Lipomics was founded in 2000.
Lipomics is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.
Lipomics was founded in 2000 in Sacramento, United States, and operated in the diagnostics sector for metabolic, cardiovascular, and inflammatory conditions. Proprietary TrueMass lipid profiling technology was utilized to offer metabolite profiling, biomarker discovery, and metabolism consultation services. Quantitative assays were applied to study disease metabolism, drug or food impacts, and biomarker identification for clinical trials and products. The company was acquired by Metabolon in August 2012.
Lipomics's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
Lipomics has 2 investors. Key investors include Metabolon, and Tethys BioScience.
Lipomics operates through Lipomics Technologies, Inc.
Yes. Lipomics was acquired by Metabolon in August 2012.